The AIDS Institute at the United States Conference on AIDS 2017

Join The AIDS Institute during the United States Conference on AIDS in Washington, DC from September 7-10, 2017. 

Follow The AIDS Institute at USCA 2017 | | Twitter @AIDSadvocacy


Thursday, September 7, 2017 | 10:15 am - 12:00 pm | Tulip, Meeting Level 2

Capacity Building: Older Adults and HIV - Working with Non-Medical Providers

This interactive session will serve as a training model for non-medical service providers and other front and mid-level staff. We will discuss the need for providers to work across disciplines to address the many needs of older adult clients. This session will discuss the co-facilitation provider training model including discussion and interactive activities. 


Lisa Frederick, Director of training Center, ACRIA

Hanna Tessema, Consultant, ACRIA

Mary McCarty-Arias, Program Manager, ACRIA

Michelle Scavnicky, Associate Executive Director,The AIDS Institute

Dr. Bambi W. Gaddist, DrPH, Executive Director, South Carolina HIV/AIDS Council

Ron L. Swanda, Vice Chairperson, District of Columbia Commission on Aging

Orisha Bowers, Community Partner, Memphis, TN


Thursday, September 7, 2017 | 2:45 pm - 4:45 pm | Pentagon, Meeting Level 4

HIV Policiy Pathway: Ensuring Funding for Domestic HIV Programs 

Sufficient funding is necessary in order to reduce the number of new infections; provide care, treatment, and housing for people living with HIV; and conduct HIV research.  This workshop will provide an update on the status of federal funding for domestic HIV programs in the first year of the Trump Administration and in a Republican controlled Congress. 


Carl SchmidDeputy Executive Director, The AIDS Institute

Carl Baloney, Jr., Director of Government Affairs, AIDS United

Nick ArmstrongPolicy Associate, The AIDS Institute

M.A. Keifer, MPH, Legislative Assistant, Office of Congresswoman Barbara Lee (D-CA, 13th)

Richard Wolitski, PhD, DirectorOffice of HIV/AIDS and Infection Disease Policy, U.S. HHS

Emily McCloskeyAssociate Director, Policy & Legislative Affairs, National Alliance of State and Territorial AIDS Directors (NASTAD)

Ronald Johnson, Vice President of Policy and Advocacy, AIDS United

Kathie HiersChief Executive Officer, AIDS Alabama

Kevin FisherDirectorPolicy, Data & Analytics, AVAC


Friday, September 8, 2017 | 9:00 am - 11:00 am | Cherry Blossom, Level 2

HIV Policy Pathway: Preventing HIV in the Trump Administration 

The CDC has reported that the number of new HIV infections overall has declined in the U.S in recent years, but progress is uneven, and some communities and states, continue to experience higher rates.  This includes gay and bisexual men, particularly those who are young, black and Latino.  This workshop will examine the current status of HIV prevention efforts in the U.S. and the key elements of CDC’s high impact prevention.  


Carl Schmid, Deputy Executive Director, The AIDS Institute.

Angela JohnsonAssociate Director of Prevention, National Alliance of State and Territorial AIDS Directors (NASTAD)

Kevin Jones, Med, MPHExecutive Director, Urban Coalition for HIV/AIDS Prevention Services

Carolyn McAllasterDirectorHIV/AIDS Policy Clinic, Duke University School of Law

Ronald Johnson, Vice President of Policy and Advocacy, AIDS United

Guillermo Chacón, President, Latino Commission on AIDS

Jesse Boyer, Senior Policy Manager, Guttmacher Institute

Monique TulaExecutive Director, Harm Reduction Coalition

Marvell Terry, HIV & AIDS Project Manager, Human Rights Campaign


Friday, September 8, 2017 | 2:00 pm - 4:00 pm | Cherry Blossom, Level 2

HIV Policy Pathway: Ending HIV in the Trump Era: Risk or Opportunity? 

A comprehensive set of federal HIV policies and implementation plans are crucial to keeping the country on course for ending the domestic HIV epidemic. Clear polices and progress on action plans are indicators of how the administration prioritizes the federal response to HIV. This workshop will examine the Trump administration’s approach to the domestic HIV epidemic and the impact that the administration is having on federal HIV policy. 


Ronald Johnson, Vice President of Policy & Advocacy, AIDS United

Carl Schmid, Deputy Executive Director, The AIDS Institute

Tim Westmoreland, JD, Professor from Practice, Georgetown Law School

Jeff Crowley, Program Director Infectious Disease Initiative, O'Neill Institute for National and Global Health Law

Jaron Benjamin, Vice President, Community Mobilization & National Advocacy, Housing Works

Ulysses Burley III, Owner/Consultant, UBtheCURE, LLC

Nic Carlisle, Executive Director, Southern AIDS Coalition



Friday, September 8, 2017 | 4:15 pm - 6:15 pm Cherry Blossom, Level 2

HIV Policy Pathway: Ensuring Access to Care: Counting on the Ryan White Program 

The Trump Administration has identified the Ryan White Program as a highly effective program, yet almost every federal program serving people living with HIV is under pressure from budget cuts or the potential of being realigned or eliminated.  Hear from Ryan White Program Policy Experts, Administration Officials and Congressional staff on the future of the Program, the potential for change and provide discussion input on how best to enhance our health care system to end HIV in the U.S.  


Ronald Johnson, Vice President for Advocacy and Policy, AIDS United

Carl Schmid, Deputy Executive Director, The AIDS Institute

Heather Hauck, Deputy Associate Administrator for HIV/AIDS Bureau,HRSA

Waverly Gordon, Professional Staff, House Committee on Energy and Commerce

Ann Lefert, Senior Director Policy & Legislative Affairs, NASTAD, Co-Chair Ryan White Work Group

Graham Harriman, Director, Care and Treatment, Bureau of HIV/AIDS Prevention and Control, NYC DOHMH

Eduardo Alvarado, HIV/AIDS Director,Illinois Department of Public Health

Ernest Hopkins, Director of Legislative Affairs, San Francisco AIDS Foundation

Dr. Deborah Morris-Harris, Chief Medical Officer, Prism Health

Daria Boccher-Lattimore, DrPH, Assistant Professor, Columbia University Mailman School of Public Health


Saturday, September 9, 2017 | 2:00 pm - 4:00 pm | Marquis Salon 12, Meeting Level 2

Session Seven: JUSTICE FOR ALL! Protecting Civil Rights through HIV Advocacy for Black Communities

The objective of this workshop will be to explore the intersection of Civil Rights and HIV Advocacy affecting Black communities. Session participants will participate in a panel discussion that will provide an analysis of the critical issues that Black people need to advocate for before our leaders in Congress and other legislative bodies. The discussion will provide additional information and context that can be used to support advocacy for congressional office visits, state and local stakeholder meetings, and future national advocacy efforts. 


Venton C. Hill-Jones, MSHCAD, PMP, Program Officer, LGBTQ Health and Wellness Initiatives,National Black Justice Coalition

Cornelius Baker

Dr. Ivy Turnbull, Deputy Executive Director, AIDS Alliance

Valerie Rochester, MPA, Vice President for Program Strategy,AIDS United


Sunday, September 10, 2017 | 9:00 am - 11:00 am | Senate, Meeting Level 4

Session Nine: The Promise of Viral Hepatitis Elimination in the United States

This year the National Academies of Sciences, Engineering and Medicine released a report entitled “A National Strategy for the Elimination of Hepatitis B and C.” In it, they made a series of recommendations that, if followed, serve as a blueprint to prevent new infections, cure existing HCV infections and treat and manage hepatitis B until a cure is discovered. This session will review this plan, provide hepatitis elimination examples from a city, state and national level, and discuss key opportunities to incorporate hepatitis services into existing HIV programs, advancing elimination efforts.


Elizabeth Paukstis, MA, JD, Public Policy Director, NVHR

Katie Burk, MPH, Syringe Access Service Community Mobilization Manager, Harm Reduction Coalition

Frank HoodPolicy Associate – Hepatitis C, The AIDS Institute